| Pharmaceuticals | Prescription drugs for oncology, transplantation, neurosciences, and chronic diseases. | Exclusive marketing rights, strong R&D, established brand reputation. | B2B healthcare providers and hospitals in India. | Specialty oncology and transplant drugs. | 356 | 90 | Sales of branded pharmaceuticals to healthcare providers and hospitals. | Sales-based revenue with strategic pricing aligned to market and regulatory norms. | Rising chronic disease cases, government health initiatives, product innovation. | Glivec, Voveran, Simulect, Certican, Myfortic |
| Generics | Generic medicines across multiple therapeutic areas. | Global generics brand Sandoz, cost-efficient manufacturing. | Pharmacies, healthcare providers; mainly B2B. | Select high-demand generics with scale advantage. | 39 | 10 | Sales of generic medicines to distributors and pharmacies. | Competitive direct sales with volume incentives. | Expanding generics demand, cost-effective alternatives, government support. | Sandoz generics portfolio |
